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“Cancer, diabetes, and heart diseases are no longer the diseases of the wealthy. Today, they 
hamper the people and the economies of the poorest populations even more than infectious 
diseases. This represents a public health emergency in slow motion.”  
                            Ban Ki-Moon, United Nations Secretary-General 
 
“I have high blood sugars, and Type 2 diabetes is not going to kill me. But I just have to eat 
right, and exercise, and lose weight, and watch what I eat, and I will be fine for the rest of 
my life.” 
 
                              Tom Hanks, famous American actor and diabetes patient 
 
 
 
 
 
 
“The doctor of the future will give no medicine, but will the patient in the proper use of 
food, fresh air and exercise.” 
Thomas Edison, American inventor and businessman 
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ABSTRACT (300 words) 
ASSESSMENT OF TYPE 2 DIABETES OUTPATIENT MANAGEMENT PRACTICE IN     
PUBLIC HOSPITALS, KHARTOUM AND GEZIRA STATES, SUDAN 
                                         M Y Elhendi1, G BJUNE2, and A El Sony3  
1
MD, University of Khartoum, Sudan. MPhil International Community Health, University 
of Oslo, Norway.   
2
 Professor, Institute of Health and Society, Faculty of Medicine, University of Oslo, 
Norway. 
3
 Professor,  Epi-Lab, Khartoum, Sudan. Past-president of the IUATLD. 
 
BACKGROUND: Type 2 diabetes is a major public health problem with an estimated 
prevalence of 8.3% among adults in 2013. Majority of diabetes mortality occurred in low and 
middle income countries as almost 80% of people with diabetes lives in these countries. Diabetes 
care exerts a tremendous economic burden on patients, families, health systems and the society 
as a whole.  
AIM: The main objective of the study is to investigate the care providers’ adherence to the 
national guideline on type 2 diabetes outpatient management.  Furthermore, to compare 
documented diabetes care services between the public hospitals and the specialized diabetes 
center. 
METHODS: This hospital based cross sectional study was in three public hospitals in Khartoum 
and Gezira states. Medical records reviewing and quantitative questionnaire included 261 
patients (mean age, 54 ±14.5 years; diabetes duration, 8.1 ±7.6 years). Additionally, Medical 
records of 157 patients were reviewed in a specialized diabetes center (mean age, 56 ±11.4 years; 
diabetes duration, 10.0 ±7.0 years).  
RESULTS: Frequency of documentation of diabetes process measures in public hospitals was: 
Blood glucose tests (67.2%), HbA1c (22.9%); foot exam (14.1%); Fundoscopy (9.2%); lipids 
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profile (17.2%); urinalysis (15.6%); and RFT (29.4%). Patients reported excess of received 
diabetes care measures compared to what is documented. In the specialized diabetes center, the 
frequency of documentation of the previous measures was significantly higher.  
CONCLUSIONS: The study identifies various areas of suboptimal diabetes care for potential 
improvement. Based on revised clinical notes, screening for diabetes complications is a low 
adherence area as the screening tests were documented in less than one third of the tested 
sample. We also found discrepancy between the documented diabetes care measures and the 
performed measures as reported by patients. The previous finding could indicate lack of proper 
documentation of the medical consultations.  
Keywords: adherence, type 2 diabetes, guidelines, outpatient management. 
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List of Abbreviations 
ADA                    American Diabetes Association 
BMI                     Body Mass Index 
BP                       Blood Pressure 
FBG                     Fasting Blood Glucose 
FMoH                  Federal Ministry of Health 
HbA1c                 Glycosylated Hemoglobin 
HDL                    High Density Lipoprotein 
GDP                    Gross Domestic Product  
IDF                     International Diabetes Federation 
IDPs                    Internally Displaced Persons 
LDL                   Low Density Lipoprotein  
LMICs                 Low and Middle Income Countries 
RFT                    Renal Function Test 
WHO                 World Health Organization 
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1. Introduction 
1.1 Sudan background: 
1.1.1 Country profile: 
Sudan is the third largest African country with an area of 1.9 million square kilometers. 
According to the 2012 census, its population is estimated around 36 million, with 17% of the 
population living in the capital city, Khartoum (1).  Sudan has 853 kilometers long coastline with 
the Red Sea and share borders with seven countries namely Egypt, Libya, Chad, Southern Sudan, 
Central African Republic , Eritrea and Ethiopia. Sudan has a characteristic location linking 
between the Arabic North African countries and Sub-Saharan Africa. Its terrain is generally flat, 
featureless plain, mountainous in the northeast and west while the north is dominated by desert 
(9). 
Sudan’s geography and the vast distances between populous areas combined with the poor roods 
and transportation infrastructure affect the delivery of health care services. The free borders with 
multiple countries help transmission of communicable disease and reduce the efficacy of 
diseases control programs.  
1.1.2 Demography: 
According to the national census performed in 2012 after the secession of South Sudan, total 
population was estimated at around 36 million, growing by a rate of 2.8% annually, 49% of the 
population living in urban areas with 17% of the population living in the capital city, Khartoum 
(12). The country has a wide range of ethnicities and cultures which constitute a combination of 
indigenous inhabitants of the Nile Valley, and descendants of migrants from the Arabian 
Peninsula (2).   
 Almost 8% of the population is nomads in cyclical migration, seeking natural resources and 
grazing areas. There are more than 2 million Internally Displaced Persons (IDPs) in Sudan due to 
the long standing conflicts and disputes. 1.4 million IDPs reside in institutions while the rest live 
in refugee camps (13).   
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The average household size is 5-6 individuals, fertility rate is 5.6 children per woman; crude 
birth rate is 31.2 and crude death rate is 16.7 per 1,000 people. Life expectancy at birth is 59 
years which is slightly higher for females (14). 
 
Figure 1.1.1 Sudan boundaries, states and important cities 
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1.1.3 Economy: 
Sudan is considered rich in natural resources and agricultural capacity but failure to manage 
these resources combined with protracted conflicts and political instability created an extremely 
poor country. Recent economic indicators showed that the Gross Domestic Product (GDP) 
equals to $159.5 billion growing at a rate of 3% in 2014 and Per capita GDP of 4,500 USD. 
According to the Human Development Index (HDI), developed by the UN Development 
Program (UNDP) in 2013, Sudan is ranked number 166 out of 187 countries (15). Since the year 
1999, the national budget was dependent on oil exports but with the separation of South Sudan in 
2011, three quarters of the oil production were lost.  However, there is slight economic growth 
currently, due to non-oil exports such as Arabic gum and gold mining. Nearly half of the 
population is considered below poverty line with less than one US dollar earning a day (16).  The 
unemployment rate estimated in 2012 was 20% while 80% of the working force employed in 
agriculture (16).   
1.1.4 Health care system: 
The Ministry of Health (MoH) is the main health care provider and it is organized in a three-tier 
system. The Federal MoH is responsible for formulation of national health strategies, training, 
monitoring, evaluation and relations with external organizations. The State MoH has the same 
responsibilities confined only to the state level, in addition to funding and implementation of 
health plans.  Localities are involved directly in health care delivery to the community through 
primary health care approach which includes Primary Health Care Units (PHCU), physician 
health centers, dispensaries and dressing units (22). The second level includes rural hospitals 
which have more trained staff and capacity to receive emergency cases. The capacity of these 
hospitals is usually 30-50 beds and represents the first referral care. The tertiary level includes 
the specialized hospitals found in the state capitals to represent the second referral destination 
(23).    
Sudan’s economy has suffered a major shock from the loss of oil exports revenue after the 
separation of South Sudan which represented 75% of the country’s budget. Consequently, health 
and other social sectors became underfunded which resulted in several health programs being 
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funded by international organizations either directly or through the Ministry of Health. Thus, 
these donor funded programs are organized in a vertical fashion and not fully integrated into the 
main stream health care system. Health insurance program, besides its role in funding individual 
patients, is a main health care provider through its owned health facilities. Other governmental 
sectors such as armed forces, police and certain universities run a considerable percentage of 
public hospitals (23).  
1.1.5 Diet and life style: 
Rural areas in Sudan are more affected with the economical adversity and the ongoing civil 
conflicts, which led to populous migration towards urban areas. Consequently, the population 
adopted more sedentary life style and developed unhealthy eating habits such as heavy 
consumption of sugar and refined wheat. Vegetables and fruits are not widely used because of 
the high cost of storage and lack of health education.  
In 2011, a national qualitative study was conducted to assess the health risk behavior associated 
with non-communicable diseases. The study found that few respondents were engaged in regular 
exercise. Although the awareness about healthy diet was adequate, majority of respondents had 
contradictory attitude. Most of the respondents had higher consumption rates of red meat, white 
sugar and salt while fruits and vegetables were less frequently used (18).  
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1.2 Diabetes mellitus 
1.2.1 Diabetes definition and classification 
Diabetes mellitus is a chronic, lifelong disease caused by deficiency or resistance of the hormone 
insulin which regulates the level of glucose in the blood. The marked hyperglycemia associated 
with diabetes gives rise to serious microvascular and macrovascular complications and damage 
of many body’s systems. Table 1.2.3 summarizes the diagnostic criteria for diagnosing diabetes 
and intermediate hyperglycemia as recommended by the World Health Organization (WHO) (3). 
There are three major types of diabetes namely type 1, type 2 and gestational diabetes. The 
chronic types of diabetes (type 1 and type 2) have different etiological factors (table 2). 
 
1.2.2 Complications of diabetes 
Diabetes is a systemic disease that affects most of the body organs especially heart, blood 
vessels, kidneys, eyes, nerves and teeth. In high income countries, diabetes is the leading cause 
of chronic heart diseases, renal failure, blindness and non-traumatic lower limb amputation (4). 
Numerous complications may arise as a result of diabetes, which include the following: 
Cardiovascular diseases: 
Chronic hyperglycemia and dyslipidemia affecting the blood vessels is a major cause of 
atherosclerosis which may lead to fatal myocardial infarction or cerebral stroke. Cardiovascular 
diseases are the most common cause of mortality in diabetic patients. (4) 
Diabetic nephropathy: 
The metabolic and hemodynamic changes associated with diabetes can lead to glomerular 
sclerosis and fibrosis. Diabetic nephropathies manifest as progressive albuminuria, increased 
blood pressure and even end-stage renal disease. Type 2 diabetes leads to renal failure in 20-30% 
of patients especially in patients with longer duration since diagnosis (usually ≥10 years) (5).  
Diabetic eye disease: 
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A range of eye problems may occur as a complication of diabetes, which include: 
Diabetic retinopathy: damage to the small vessels in the retina leads to poor vision or even 
blindness. 
Cataract: Diabetes accelerates the onset of cataract which is clouding of the eye lenses. 
Glaucoma: increase in the vitreous fluid pressure resulting in optic nerve damage, retinal 
detachment and loss of vision. 
It is estimated that 39 million cases of blindness worldwide are caused by diabetes and 248 
million diabetics are visually impaired (24). 
Diabetic neuropathy: 
Diabetes affects the small vessels that supply the nerves which lead to neuronal dysfunction 
especially in the peripheral nerves and the autonomic nervous system. Adverse consequences of 
diabetic neuropathy include diabetic foot ulceration and lower limb amputation, diabetic 
gastropathy and erectile dysfunction in men. In addition, it may mask the symptoms of ischemic 
heart disease, resulting in the clinically ambiguous silent angina. 
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Table 1.2.3 WHO diagnostic criteria of diabetes and intermediate hyperglycemia 
Diabetes mellitus 
Fasting plasma glucose                       
or 
2–h plasma glucose*        
≥7.0mmol/l (126mg/dl) 
 
≥11.1mmol/l (200mg/dl) 
Impaired Glucose Tolerance (IGT) 
Fasting plasma glucose 
and 
2–h plasma glucose* 
< 7.0mmol/l (126mg/dl) 
 
≥7.8 and <11.1mmol/l  (140mg/dl to 
200mg/dl)                                                                                                                    
Impaired Fasting Glucose (IFG) 
Fasting plasma glucose 
and (if measured)                                                                                                                               
2–h plasma glucose* 
6.1 to 6.9mmol/l (110mg/dl to 125mg/dl) 
<7.8mmol/l (140mg/dl) 
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Classification of diabetes according to etiological factors 
Type 1 diabetes (complete lack of insulin due 
to destruction of beta cells in the pancreas) 
Type 2 diabetes (insulin resistance with or 
without reduced insulin secretion) 
Autoimmune 
Idiopathic 
Multifactorial (genetic susceptibility combined 
with other behavioral risk factors) 
Hereditary  beta cell dysfunction 
Genetic defects in insulin processing or action 
Exocrine pancreatic defects  
Endocrinopathies e.g. Acromegaly  
Viral infections  
Drugs 
 
1.2.3 Diabetes care 
Diabetes is complex and multisystem disease that requires management through systematic and 
multifaceted approach which relies on certain clinical guidelines. Periodical guidelines on 
management diabetes are provided by major organizing bodies such as the World Health 
organization (WHO), International Diabetes Federation (IDF) and the American Diabetes 
Association (ADA) (25-27).  The previous guidelines stated that management of diabetes should 
not be confined to lowering the blood glucose level only but also extend to life style 
modifications and lowering the risk of developing diabetes complications. Moreover, it 
emphasizes on educating patients on self monitoring and management. Additionally, the IDF 
published guidelines in 2013 regarding management of type 2 diabetes in older population (28). 
The guidelines provided solutions for numerous challenges in management of diabetes in old 
people with special focus on long term diabetes complications. The guidelines, also, addressed 
less commonly tackled areas such as pain management and end of life care.  
In 2011, the Federal Ministry of Health in Sudan constituted national guidelines to manage 
different types of diabetes (48). The guidelines were mainly based on the WHO 
recommendations but certain modifications were introduced to adapt to the local setting, 
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especially the financial aspect. In our study, these guidelines were considered the standard 
reference for diabetes care in Sudan. The following points highlight the main features of the 
above mentioned guidelines: 
 The recommended management team consists of, at least, a general practitioner, diabetes 
educator, Nutritionist and a nurse. High risk patients should be referred to specialized 
units for screening and management of diabetes complications. 
 In addition to the management team, the outpatient clinic should include adequate space 
and time for patients, system of documentation of diabetes consultations and means of 
referral and communication with specialized units. 
 The guidelines define four areas to be included in the comprehensive management of 
diabetes patients: 
1.  Medical history: Characteristics of patients, life style and eating patterns, drug 
history, diabetes-related complications and knowledge about self-management. 
2. Complete physical exam: BMI, blood pressure, comprehensive foot exam, 
Fundoscopy, neurological exams. 
3. Laboratory assessment: blood glucose tests (FBG, RBG and HbA1c), fasting lipid 
profile and urinalysis for microalbuminuria. 
4.  Treatment plan: Medications used in glycemic control and treatment of 
associated risk factors i.e. dyslipidemia, hypertension and obesity. 
 The detailed plan of the tasks that should be performed during the follow-up visit and 
annual review are shown in Table 5. The guidelines lacked recommendations on the 
structure of medical documentation e.g. predesigned medical card/file for diabetes 
consultation. Thus, in developing the review checklist for the current study, we assumed 
that all the suggested tasks should be documented. 
 The guidelines mentioned two tests for monitoring of glycemic control, which are fasting 
and postprandial glucose level (at each visit) or HbA1c (every 3 months). In contrast to 
the international guidelines published by the WHO and the IDF where HbA1c is the only 
recommended test for monitoring of glycemic control. The added option may be due to 
the high cost and reduced availability of HbA1c in Sudan. 
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Table 1.2.3 Components of the medical consultation during diabetes follow-up visits 
 
Review topics 
 
 
Initial review/ Referral 
 
Regular 
 
Annual 
review 
Long term and/or recent diabetes history      
Life style review       
Complications history and/or examination      
Smoking history   If 
problem 
  
Drug history / current drugs       
Weight/ body mass index       
General examination     
Foot examination   If 
problem 
  
Eye vision examination   If 
problem 
  
Blood pressure   If 
problem 
  
Glycosylated hemoglobin       
Lipid profile   If 
problem 
  
Urine protein        
Serum creatinine   If 
problem 
  
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 The guidelines emphasize that foot care is essential in diabetics and all physicians must 
perform foot exam regularly. Also, physicians should advice patients on suitable shoes, 
nail cutting and self inspection of the feet.  
 In type 2 diabetes, unlike other types of diabetes, screening for diabetes complications 
should start directly after the establishment of the diagnosis and continue annually.   
 The guidelines provided standard targets for diabetes care measures and laboratory tests. 
The standard targets differ occasionally from the targets recommended in other 
guidelines, so it is assumed that it is more compatible with diabetes patients in Sudan or 
the region. The following table shows the recommended targets for diabetes care. 
 
 Targets of diabetes care measures/tests 
               Test/ measure Target value 
Blood pressure, mmHg <130/80 
Body mass index, Kg/m2 <25 
HbA1c, % <6.5 
Total cholesterol, mg/dl <200  
LDL cholesterol, mg/dl <100 
Serum creatinine <1.09 
 
1.2.4 Global burden of Diabetes 
In 2013, the international Diabetes Federation (IDF) estimated that 382 million people suffer 
from diabetes worldwide, with a prevalence of 8.3% among adults (16). There is a great increase 
in the prevalence of diabetes especially in developing countries due to the epidemiological 
transition of health risks towards modern risks such as sedentary life style and unhealthy food 
rather than the health risks associated with communicable diseases. The increase in the 
prevalence of diabetes could also be caused by improved survival and aging of people and 
improved disease detection and diagnosis. 
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Chronic non communicable diseases, including diabetes, are the leading cause of death globally. 
WHO recent estimates showed that diabetes caused 1.5 million deaths in 2012, constituting 2.7% 
of total deaths (18). Majority of diabetes mortality occurred in low and middle income countries 
as almost 80% of people with diabetes live in these countries.  
The burden of diabetes is clearly underestimated as statistics showed that almost 50% of diabetes 
cases are undiagnosed worldwide (the IDF estimated 175 million undiagnosed cases currently) 
(16). Late diagnosis is a major issue as it reduces the chance of preventing long term 
complications of diabetes. Moreover, the mortality is less quantified as diabetes is not recorded 
as the cause of death in considerable proportion of cases but the cause is attributed to its 
complications that led directly to death (17). For example ischemic heart disease is the leading 
cause of death worldwide (7.4 million deaths in 2012) and it is a prevalent complication of 
diabetes. 
Diabetes is the leading cause of the following: Chronic Kidney Disease (CKD), adult onset 
blindness and non-traumatic lower limb amputation (19-21). Also, it is a major cause of stroke 
and ischemic heart disease.  
1.2.5 Diabetes in Sudan 
Knowledge of the diabetes epidemic in Sudan is deficient as there is no national survey or large 
scale studies to quantify the burden of the disease on the country. The WHO and the IDF 
published estimates on the prevalence and burden of diabetes in Sudan depending on small scale 
reports, comparisons to similar countries and predictive models, thus, high degree of uncertainty 
is suspected.  
The WHO estimated the prevalence of type 2 diabetes in Sudan to be 3.5% among males and 
3.4% among females (16). The previous WHO figures are suspected to be adopted from a small-
scale study conducted in 1996 to estimate the prevalence of type 2 diabetes in northern states 
with a sample of 1,284 subjects aged 25 years or more (17). In 2014, the IDF estimated that 16% 
of Sudanese adults (20-79 years) suffer from diabetes, with a total of 3 million diagnosed 
patients and additional 1.5 million cases suspected to be undiagnosed (18).   
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Another study carried out in 1998 indicated a higher prevalence among Danagla community; a 
major tribe resides in northern Sudan. The prevalence of type 2 diabetes was 8.3% (men 9.9%; 
women 7.5%) and showed no differences between rural and urban areas (19).  
In recent years, the Federal Ministry of Health (FMoH) conducted small scale studies, in line 
with the 2010 Sudan Household Survey (SHHS) (14), to calculate the prevalence in different 
areas of Sudan. The figures showed great differences between various regions. The prevalence of 
type 2 diabetes ranged from 2% in the western most state of West Darfur to as high as 24% in the 
Northern state. The FMoH estimated that the prevalence of type 2 diabetes in Sudan should be 
around 14.5%. In 2006, the Ministry of Health in Khartoum state estimated the prevalence in 
Khartoum to be 19.2%. The previous figures are not published as they were not calculated 
through a specific national survey to measure the prevalence of diabetes. These estimates were 
directly collected from the department of non-communicable diseases in both ministries.   
In addition, Diabetes care exerts a tremendous economic burden on patients, families, health 
systems and the society as a whole. Direct costs of diabetes include expenses of diagnostic tests, 
diabetes medications, outpatient consultations, hospitalizations and travel to health facilities. 
Additionally, there is greater burden of indirect costs such as disabilities, short illnesses, time of 
family caregivers and psychological issues. There is paucity of information on the expenses of 
diabetes control in Sudan. M.Eltom et al. and associates estimated the direct costs of managing 
type 2 diabetes in Khartoum as 175 USD per year. The previous study found no relation between 
higher cost of diabetes care and optimum glycemic control, as 77% of patients (total of 822) had 
unsatisfactory level of HbA1c (17). 
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1.3 Literature review of relevant studies: 
1.3.1 Search strategy 
The literature search involved review of mainly two online data bases, PubMed and Google 
scholar. The used search key words, the number of hits and the narrowing criteria are listed 
below: 
 
#1 management of type 2 diabetes : 3546 Hits 
#1 #2 assessment OR evaluation OR audit : 650 Hits 
#1 #2 #3 publication date: last 10 years 
#1#2#3 #4 Review articles: 185 articles 
 
 
There were two articles suggested by an expert. So, the total number of retrieved articles for 
further review at the title/abstract level was 187 articles. The following diagram shows the 
pathway to obtain the relevant articles which were included in the literature review.   
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Figure 1.3.1: search strategy for relevant articles  
 
 
 
 
 
 
Number of citations reviewed for inclusion at 
the  
Title/Abstract level = 185 
Total number of full text articles retrieved 
and evaluated for inclusion = 14 
ARTICLES INCLUDED 
= 5  
Total number of citations excluded at the 
title/abstract stage = 167 
ARTICLES EXCLUDED 
= 9 
Relevance =  4   
e.g., assessment of  self 
management  
Setting = 1  
assess. of private specialized 
center 
Population = 1   
 pregnant women Gestational 
DM 
Design= 2   
e.g., drug trials  
Research area = 1 
 lipid control in DM patients  
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1.3.2 Overview of the relevant studies 
Generally, the used methods in the relevant studies are different according to the study setting. In 
developed countries, clinical auditing is an establish practice in health facilities. Thus, the 
published studies tried to assess the outcome of management or to target particular health care 
level e.g. family doctors. In developing countries, the studies usually aim to describe the 
management practice and implementation of clinical guidelines. Another difference, the quality 
of medical documentation in low income settings is often questionable, so additional tools such 
as interviewing diabetes patients and health care providers are applied. In developed setting, 
review of medical records is the main tool for assessing diabetes management.    
In low resource settings, it is widely noticed that the patients tend to bypass the primary care 
level in favor of higher level of care despite the greater time and financial costs. Although there 
is no study in Sudan to prove the previous fact, it is well documented in similar developing 
countries. Consequently, the studies conducted in developing countries tend to target hospitals as 
diabetes patients usually seek care in the secondary level, in contrast to the developed countries, 
where the follow up of diabetes patients is provided mainly through family physicians or general 
practitioners.  
1.3.3 Knowledge gap 
There is limited research on diabetes and other communicable diseases conducted in Sudan. The 
rapid epidemiological shift towards communicable diseases is unmatched with change in 
research priority and funding. In regard to the management of type 2 diabetes in Sudan, there is 
lack of tools to measure the implementation of published guidelines. For example, clinical 
auditing of diabetes is not widely implemented to assess the quality of provided care. In addition, 
scarcity of published studies on quality of diabetes management in Sudan creates a wide 
knowledge gap in the field. The reviewed studies lacked comparison of the documented diabetes 
measures to the measures reported by patients. The previous finding gives better understanding 
of the quality of diabetes care, as collecting data solely from medical records could 
underestimate the performance.   
 
Mazin Yousif Elhendi – Master thesis in International Community Health, Oslo 
25 
 
1.3.4 Rationale of the study 
The prevalence of non-communicable diseases, including diabetes, is increasing globally without 
equivalent increase in research and funding to combat these diseases. In Sudan, and other 
developing countries, the increase is more dramatic due to the changes in life style and aging of 
the population. So, the developing countries are struggling with double burden of risk factors for 
communicable and non-communicable diseases. In a setting of low human and funding 
resources, the current practice of managing diseases needs to be consolidated to obtain the 
desirable outcome. 
Assessment of the management practice is essential to evaluate the impact of current and future 
interventions. It is also important to understand the extent of implementation of published 
guidelines. Thus, such studies can trigger health facilities to establish a routine clinical audit to 
monitor the performance of care providers and transmit feedbacks to the policy makers. 
Additionally, assessment of the practice helps further studies to assess the outcome of the used 
management guidelines. Based on the reviewed literature, most of the studies were assessing the 
outcome measures of diabetes care and attainment of the standard management goals. But, in 
most developing countries the management practice and the medical documentation is lacking 
which affect assessing the management outcome.  As to best of my knowledge, there are no 
published studies on describing the follow up and management of type 2 diabetes in the 
outpatient settings in Sudan, so I would like to explore this gap.  
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2. Objectives of the study 
2.1 General objective 
The main objective was to map the adherence to clinical guidelines for management of 
type 2 diabetes in outpatient clinics using review of medical records and reporting of 
patients on provided diabetes care services. 
 
Research Question: 
What is the level of adherence between the guidelines for management of type 
2 diabetes and the actual practice in outpatient clinics in Sudan? 
 
 
2.2 Specific objectives 
 To evaluate the degree to which type 2 diabetes patients receive the recommended 
diabetes care measures regarding glycemic control, life style interventions and 
risk assessment as outlined in the national guidelines on management of diabetes. 
 To compare documented diabetes care services between the public hospitals and 
the specialized diabetes center. 
 To identify which of the patients’ characteristics and disease related variables 
have a significant relation with the receipt of diabetes care. 
 To know the frequency of diabetes complications. The study focuses on the 
common complications of Type 2 diabetes that affects the eyes, feet, heart and 
kidneys. 
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3. Methods 
3.1 Study design and setting 
The study conducted as a descriptive cross sectional, hospital based study. The study was 
based on collecting primary data (patients’ questionnaires) and secondary data (review of 
medical records). The study was designed to map the management and follow up of patients 
in outpatient clinics as reflected from medical records and reporting of patients on diabetes 
care measures. It was between October 2014 and January 2015. 
 
3.2 Study population 
The target population consisted of all type 2 diabetes patients attending the weekly outpatient 
clinics of the targeted hospitals during the study period. In the specialized diabetes center, 
only patients’ files were included.  
Inclusion and exclusion criteria: 
Patients included in this study were patients whom diagnosed with type 2 diabetes and started 
follow up in the target hospitals at least one year prior to the study period. This is to insure 
inclusion of variables regarding annual diabetes care measures. In addition, included patients 
should have a follow up card or file filled with variables from previous medical consultations 
in the target hospitals. 
Excluded patients were those with other types of diabetes, critically ill patients and patients 
who did not attend follow up clinics in the past year. 
 
3.3 Study sample 
The study designed as a descriptive study to quantify diabetes care aspects provided by 
management units measured mainly through review of medical records. Thus, the target 
population was type 2 diabetes patients attending the outpatient clinics of the health facilities 
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under study. The sample size of the reviewed medical records was determined using Java 
applets sample calculator. It was calculated that a sample size of 385 medical records would 
be required to achieve 95% confidence level. It was estimated through a small pilot study in 
one of the target hospitals that the number of type 2 diabetes patients attending the outpatient 
clinic per week was around ten patients. Considering the limited time for data collection, the 
aim was to interview 250 patients in the three public hospitals. 
The eventual sample size was 261 interviewed patients and reviewed medical records in the 
public hospitals, in addition to 157 reviewed medical records in the specialized diabetes 
center. In public hospitals, type 2 diabetes is managed within the department of internal 
medicine, thus, limited number of diabetes patients is available at each outpatient clinic. 
Consequently, recruitment of participants aimed total coverage of type 2 diabetes patients 
attending the targeted outpatient clinics during the period of the study. 
3.4 Data collection tools 
Obviously, the suitable tool for auditing the clinical management in health facilities is 
observation of the practice of care providers. It was inconvenient to adopt this tool because 
the recommended diabetes measures are not required at each medical consultation. Certain 
measures required once per year or every 4 months, e.g. glycosylated hemoglobin test. 
Moreover, observation in outpatient settings can lead to change in the attitude of care 
providers. 
Eventually, the used data collection tools were: 
1. Medical records review checklist: developed from the guidelines on management of 
diabetes published by the Sudanese federal ministry of health in 2011 and following the 
recommendations of the World Health Organization (WHO). The guideline showed the 
required measures for management and follow up of diabetes patients and the period of 
performing each measure. On the other hand, there were no clear guides on 
documentation of performed diabetes care measures during the medical consultation. So, 
the checklist included variables with the assumption that all measures should be recorded. 
The review checklist was the only tool used in the specialized diabetes center. 
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2. A structured questionnaire: administered to type 2 diabetes patients attending the targeted 
outpatient clinic. The questionnaire was used to describe certain demographic and clinical 
features of patients in addition to recalling of the received diabetes care measures. It was 
noticeable during the pilot study that requested investigations reports were usually carried 
by patients, so, additional time during the interview was allocated to check the 
investigations reports that were brought along with patients but not recorded in follow 
cards or files. 
 
 
Variables collected from the medical records review: 
A. Diabetes related clinical history: 
1. Symptoms related to diabetes and its complications 
2. History of current diabetes medications 
3. Smoking status  
B. Diabetes related physical exam: 
1. Weight measurement and recording of BMI 
2. Recent blood pressure measurement 
3. Feet exam within the last year 
4. Eye exam (fundoscopy) within the last year 
5. Peripheral pulses examination 
C. Diabetes related laboratory investigations: 
1. Recent plasma glucose level 
2. Glycosylated hemoglobin level within the last 4 months 
3. Lipids profile for total cholesterol and LDL level 
4. Serum creatinine level  (renal function test) 
4. Statistical analysis: 
  Statistical analyses consisted of descriptive statistics, Chi-square test, t-test and binary logistic 
regression. The analyses adopted a confidence level of 95% and P-value<0.05 was considered to 
be statistically significant. The collected data were normally distributed, thus mean value 
standard deviation was the main presentation. The tested criteria of diabetes care were equally 
weighted for all patients. Therefore, adherence to each criterion, as documented in medical 
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records was, presented as percentages (100% is full adherence). The association between two 
nominal variables was examined using the Pearson’s chi-squared test.  
Attainment of diabetes care therapeutic targets was quantified using clinical cut-off points as 
recommended by the standard guideline. Proportion of patients reaching the standard target was 
presented with percentage of documentation of the tested variable. Logistic regression was used 
to predict effects of covariates suspected to have association (e.g. health insurance, history of 
hospitalization, duration and complications of diabetes) on receipt of diabetes care measures. The 
effect of covariates was presented as odds ratio and confidence interval.  
3.5  Data collection procedure 
After receiving the ethical approval from the national committee, three public hospitals were 
chosen as study sites according to availability of type 2 diabetes patients and permission from the 
hospitals administrations. Pretesting included attending at least one outpatient clinic at each 
hospital. The aim of pretesting was to understand the organization of outpatient clinics in the 
targeted hospitals to determine the appropriate method for approaching patients. In addition, the 
questionnaire was presented to patients to ensure clarity and sequencing of questions. Due to the 
limited time frame and the weekly and overlapping timing of the outpatient clinics, three 
research assistants were trained on interview techniques and data extraction. The research 
assistants were newly graduated doctors and recruited in different times during the data 
collection period. 
Data collection in the specialized diabetes center started at a later time because ethical approval 
was required locally at the center. The study site was the statistics unit where files of patients 
attending the outpatient clinics are collected. 
During the study, patients were approached either in the waiting room prior to their medical 
consultation or directly after finishing the meeting with care providers. In the three public 
hospitals, type 2 diabetes patients were followed up with the internal medicine units. The 
hospitals had different arrangements for the outpatient clinics. In two hospitals, files were 
collected by the statistics unit prior to the start of the clinic. The previous arrangements allowed 
easier identification of patients fulfilling the inclusion criteria as well as faster approach to the 
patients in the clinic waiting room. In the other hospital, no such arrangement was implemented 
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so recruitment assistance was offered by care providers. The collaborated care providers 
identified type 2 diabetes patient and inquired them about the possibility of participation in the 
study. The patients then were approached by the researcher for further details. 
The average time for completing the 12-items questionnaire was 15 minutes, including time for 
checking the investigations reports carried along with patients. Additional 5 minutes were 
needed to extract data from the patients follow up cards using the checklist. On average, 20 
patients were interviewed weekly.  
3.6 Ethical considerations 
The study was designed as a quality control study for an ongoing medical practice without 
introducing new interventions, so participation involved no more than the minimal risk. The 
study has been ethically approved from the department of health researches in the federal 
ministry of health as the study is planned to involve more than one state. Additionally, 
permission to perform the study and extract data from medical records was obtain from hospitals 
directors.  
Verbal consent was obtained from participants after explaining the purpose and plan of the study. 
Recruited patients were informed that participation is voluntary and refusal will not influence 
receipt of further care. The reasons for using verbal consenting were: 
 More Feasible and less time consuming in the settings of an outpatient clinic. 
 More suitable for illiterate and semi-illiterate participants. 
 Cultural issues may be raised by patients when signing any kind of document. 
 Short time needed for participants and no side effects on patients apart from time needed 
for the interview.   
 Allowing patients to be more interactive. 
Communication of the study results: 
 The study will be presented as a master’s thesis at the institute of health and society, 
University of Oslo.  
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 Dissemination of the study results and recommendations to the interested bodies in 
the Sudanese federal ministry of health and the hospitals directories. 
 Transforming the study into an article and publishing in suitable journals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mazin Yousif Elhendi – Master thesis in International Community Health, Oslo 
33 
 
4. RESULTS  
4.1 Response rate 
During the study duration, a total of 293 diabetes patients were approached to answer the 
questionnaire after fulfilling the inclusion criteria. Medical records of the previous 
patients were reviewed beforehand. Finally, 261 patients agreed to participate in the 
study, with a response rate of 89, 07%.  
 
4.2 General characteristics 
Two hundred and sixty one patients aged twenty two years to ninety years were 
interviewed in outpatient clinics of three major public hospitals in Khartoum and Gezira 
states. Information on diabetes management was reviewed from their follow up cards. 
Table 4.2.1 includes details of the demographic and clinical backgrounds of patients. 
The average age of the study sample was in the mid-fifties (54 ±14.5) and 50.2% of all 
patients were in the age group 45-64 years. More females were represented in the study 
(54.8% female vs. 44.2% male), although the difference was not statistically significant 
(Stata Two-sample test of proportions (z=1.54, P=0.122)). Majority of patients (59.8%) 
were using oral antidiabetic agents for glycemic control compared to minor percentage 
(3.8%) were controlled by diet alone. Almost 40% of the study sample lacked health 
insurance coverage. A third of the patients reported to have high blood pressure either 
before or after diagnosis with Type 2 Diabetes. Although, 18.0% (n=47) were current 
smokers including twelve females, enquiry or advice on smoking cessation was lacking 
with only 13% of patients having a documentation on smoking status or advice on 
smoking cessation. 
In the specialized Diabetes center (Table 4.2.2), one hundred sixty two patient’s files 
were reviewed. Mean age was fifty six years and ranged from 29-90 years. Mean duration 
since diagnosis with type 2 diabetes was ten years (10.0 ±7.0). Almost sixty percent of 
the study sample were females (n=94). Although, weight was routinely measured in each 
visit (unless is disabled), measurement of height, and thus BMI, was only available in 
63% of the studied patients. The mean BMI of the documented recordings was twenty 
six. Oral antidiabetic medications were documented in 68.9% of patients (n=104), while 
eleven patients (7.3%) used no Diabetes medications. 
Mazin Yousif Elhendi – Master thesis in International Community Health, Oslo 
34 
 
 
Table 4.2.1:  Demographic and clinical data for the 262 interviewed diabetic patients in Public 
hospitals: 
Characteristics  No. (%) Mean ± SD 
Age, years  54 ±14.5 
Duration since diagnosis with Diabetes, years  8.1 ±7.6 (range 1—38) 
Gender 
Female                                                                                                                          
Male                                                                                                                               
 
143(54.8%) 
118(45.2%)
 
DM medications 
None  (Diet and exercise only)                                                                                 
Oral antidiabetic agents                                                                                           
Insulin injections                                                                                                         
Combination of oral agents and Insulin                                                                  
 
10(3.8%)
156(59.8%)
48(18.4%) 
47(18.0%) 
 
Patients with private Glucometer                                                                          56(21.5%) 
Patients enrolled in the Health insurance 
scheme                                              
154(59.0%)  
Smoking status 
Nonsmokers                                                                                                                 
Active smokers                                                                                                            
Previous smokers                                                                                                        
 
198(75.9%)
47(18.0%)
16(6.1%)
 
Comorbidities/ Organs affected by T2DM 
Hypertension                                                                                                               
Foot (peripheral neuropathy)                                                                                   
Eye                                                                                                                                 
Heart (Coronary artery disease)                                                                               
Kidney (Nephropathy)                                                                                                 
 
86(33.0%) 
65(24.9%)
68(25.9%)
30(11.5%)     
14(5.4%)
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Table 4.2.2: Demographic and clinical features reviewed from patients 
files in the Specialized Diabetes center: 
 
Characteristics 
 n=157 
No. (%) Mean ± SD 
(Range) 
Documentation (%) 
Age, years  56 ±11.4 (29-
90)                                                                                                                      
100% 
Duration since diagnosis with 
Diabetes, years 
 10.0 ±7.0 (2-
40) 
100% 
Gender 
Female                                                                                                                          
Male                                                                                                                               
 
94(59.9%) 
63(40.1%)
 100% 
Body Mass Index (BMI)  26 (17-43) 63% 
DM medications 
None  (Diet and exercise only)                                                                                 
Oral antidiabetic agents                                                                                           
Insulin injections                                                                                                         
Combination of oral agents and 
Insulin                                                                  
 
11(7.3%)
104(68.9%) 
12(7.9%)
24(15.3%) 
 96% 
Smoking status 
Nonsmokers                                                                                                                 
Smokers                                                                                                                                                                                                            
 
131(83.5%)
26(16.5%)  
 86% 
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4.3 Documentation of diabetes medical consultation 
In the public hospitals, all the tested Diabetes follow up exams and investigations, except for 
those considered as routine such as BP checks and blood Glucose measurements, were below 
30% documented. Frequency of documentation was ranging from 9.2% who performed eye 
exam (Fundoscopy) to 22.9% who had their glycosylated hemoglobin checked. Highly 
documented areas included Diabetes history, complications history and measurement of BP. 
Smoking history was documented in 13% of patients only.  
One hundred and seventy six patients (67.2%) had at least one blood glucose level test 
(FBG/RBG) during the past year but only 22.9% patients documented a glycosylated 
hemoglobin measurement. However, there were no significant demographic differences between 
them and patients who did not have glycosylated hemoglobin documented.  
Percentages of documentation in the specialized Diabetes center showed higher values in all 
tested variables. Statistical testing of proportions revealed significant differences in all similar 
variables except for documentation of glycosylated hemoglobin measurement, which was 22.9% 
in the public hospitals compared to 35% in the specialized Diabetes center. Eye exam 
(Fundoscopy) was the least documented variable in both public hospitals (9.2%) and the 
specialized Diabetes center (22.9%).  
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Table 4.3.1 Comparison between frequency of documentation of Diabetes care aspects in public hosptals 
and the specialized Diabetes center: 
 
Public hospitals:  
N = 262 
The Specialized 
Diabetes Center: 
N = 157 
 
P-value 
                     Item n (%) n (%)  
1. Long term and/or DM history  197(75.2) 157(100.0) <0.01 
2. Complications history   190(72.0) 157(100.0) <0.01 
3. Drugs History / current drugs  229(87.4) 151(96.2) <0.01 
4. Smoking status  36(13.0) 135(86.0) <0.01 
5. Serial PB readings  185(70.6) 145(92.4) <0.01 
6. BMI/Weight measurement 47(17.9) 100(63.7) <0.01 
7. Blood Glucose level (RBG/FBG) 176(67.2) 155(98.7) <0.01 
8. HBA1c (within 4 months) 60(22.9) 55(35.0) 0.155 
9. Foot examination 37(14.1) 72(45.9) <0.05 
10. Peripheral Pulses Examination 59(22.5) 102(65.0) <0.01 
11. Retinal screening (Fundoscopy)/ 
Referral to ophthalmologist 29(9.2) 36(22.9) <0.01 
12. Lipids Profile  45(17.2) 61(38.9) 0.018 
13. Urine Protein/Albumin  41(15.6) 60(38.2) 0.012 
14. Renal Function Test 77(29.4) 72(45.9) 0.030 
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Patients were asked, in the questionnaire, about receipt of selected Diabetes care measures, 
namely, eye exam (fundoscopy), foot exam by health care professional, PB measurement and 
weight measurement. Moreover, the investigator checked the results of certain investigations 
carried with patients, such as glycosylated hemoglobin, renal function test and lipids profile. The 
produced results include both the reported measures by patients and the ones detected by the 
investigator.  
In table 4.2.2, diabetes care measures reported by patients in the questionnaire are compared to 
their frequency of documentation in the patients follow up cards. In general, patients received 
more Diabetes care measures than it is documented. These differences were statistically 
significant in reporting of fundoscopy, PB checking and renal function tests. The highest 
difference was noted in reporting of fundoscopy as it is documented in 9.2% of follow up cards 
while 29.5% of patients reported having fundoscopy done in the past year. 
Reporting of received Diabetes care measures by patients (Questionnaire) ranged from 87% as in 
BP checking to 22.2% who received foot exam in the past year. 
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Table 4.3.2: Comparison of selected Diabetes care measures obtained from 
the medical records and the patients questionnaire: 
Measurement  Questionnaire 
No.(%) 
 n=261 
Checklist 
No.(%) 
 n=261 
P-value 
Fundoscopy/referral to 
ophthalmologist  
77(29.5)   29(9.2) 
 
<0.01 
Foot exam by HC personnel 58(22.2) 37(14.1) 
 
 
0.32 
PB measurement by 
Physician 
227(87.0) 185(70.6) <0.01 
Weight measurement 80(30.7)             47(17.9) 0.10 
HBA1c within the last 4 
months 
93(35.6) 60(22.9) 0.08 
Renal function test within the 
last year 
129(49.4) 77(29.4) <0.01 
Lipids profile within the last 
year 
82(31.4) 45(17.2) 0.08 
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4.4 Achievement of diabetes therapeutic targets in the specialized center 
 
This section includes results obtained only from the specialized diabetes center. The collected 
data from the public hospitals were extremely deficient regarding the values of diabetes care 
measures and investigations.  
Glycemic control: 
In the sample of 157 patients’ files, 35% of patients had their HBA1c recorded. Out of these 
patients only twelve patients (21.8%) reached the therapeutic target of less than 7% 
recommended by the standard guidelines. 
Blood Pressure control: 
Systolic and Diastolic Blood Pressure (BP) measurements were noted in 93.6% of patient files, 
revealing mean values of 125 mmHg and 77 mmHg, respectively. Considering the target value 
for adequate control of Blood Pressure of less than 130/80, one hundred and fourteen patients 
(76.6%) met the standard target. 
Diet and BMI: 
Within the study sample managed in the specialized Diabetes center, seventy patient files 
(26.8%) documented receipt of dietary consultation in the past year. Body Mass Index (BMI) 
was recorded in 30% (n=100) of patient files and the mean value was 26 kg/m2. Out of these 
patients, forty four patients (44%) were recorded to have BMI less than 25 kg/m2. 
Lipid control: 
39.5% of patient files contained values for total cholesterol and Low Density Lipoprotein (LDL) 
tests. The management target success rate was 74% for total cholesterol (the target is less than 
200 mg/dl) but only 37% of patients reached the target LDL level of less than 100 mg/dl. 
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Table 4.3 Documentation of diabetes and Diabetes complications risk factors indicators of 
157 reviewed clinical records in the specialized Diabetes center: 
Clinical 
Test/Measure 
 
Percentage of 
Documentation, 
n=157 
Mean value  
± SD 
Standard 
target 
N(%) of 
patients 
achieving the 
targets 
 
Systolic BP, mmHg 
 
93.6% 
 
125.3 ±17.4 
 
< 130 
 
114(76.6) 
 
Diastolic BP, mmHg 
 
93.6% 
 
77.6 ±10.6 
 
< 80 
 
115(78.2) 
 
BMI, Kg/m 
 
63% 
 
26 ±4.5 
 
18.5-24.9 
 
44(44.0) 
 
HBA1c,% 
 
35.0% 
 
8.1 ±2.0 
 
<6.5 
 
12(21.8) 
 
Total cholesterol, 
mg/dl   
 
39.5% 
 
176.4 ±41.4 
 
<200 
 
46(74.2) 
 
LDL, mg/dl 
 
39.5% 
 
113.0 ±41.9 
 
<100 
 
23(37.1) 
 
Serum Creatinine  
 
45.9% 
 
1.09 ±0.72 
 
<1.00 
 
42(58.3) 
BP: blood pressure, HBA1c: glycated hemoglobin, RBG: random blood glucose level, FBG: 
fasting blood glucose level, LDL: low density lipoprotein                 
 
4.5 Factors affecting performing annual diabetes care measures: 
In table 4.4, selected independent variables were included in binary logistic regression model to 
predict their influence on receipt of investigations of glycemic control and screening of 
complications. The suggested covariates include health insurance, past history of hospitalization 
and duration since diagnosis with Diabetes. The odds of receiving the selected services were 
approximately equivalent for patients with health insurance and no health insurance. Patients 
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with longer duration since diagnosis with Diabetes showed greater odds of receiving eye exam 
(fundoscopy). The proportions of patients receiving glycosylated hemoglobin and renal function 
tests were significantly higher among patients with positive past history of hospitalization. 
 
 
Table 4.4 Binary logistic regression analysis predicting receipt of Diabetes follow up 
investigations according to significant covariates: 
 
INVESTIGA-
TION 
 
Fundoscopy 
n=77 
 
HbA1c 
n=93 
 
RFT 
n=129 
 
Lipid profile 
n=82 
 
COVARIATE 
OR (95% 
CI) 
P-value OR 
(95% 
CI) 
P-value OR 
(95% 
CI) 
P-value OR 
(95% 
CI) 
P-value 
Insurance 1.5 
(0.8-2.8) 
0.1 1.4 
(0.8-
2.4) 
0.2 1.1 
(0.6-
1.9) 
0.6 1.0 
(0.6-
1.7) 
0.8 
Hospitalization 0.5 
(0.3-0.9) 
0.04 0.8 
(0.5-
1.4) 
0.5 2.6 
(1.6-
2.4) 
0.000 1.3 
(0.7-
2.2) 
0.2 
Duration of 
DM 
 
 
1.06 
(1.0-1.1) 
0.001 1.01 
(0.9-
1.05) 
0.3 1.0 
(0.9-
1.0) 
0.2 1.0 
(0.9-
1.0) 
0.5 
HBA1c: glycated hemoglobin, RFT: renal function test, OR: odds ratio, n: number of patients 
who receipt the investigation, Bold if P < 0.05 
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4.6 Purpose of annual Diabetes care measures 
Annual Diabetes care measures, such as renal function test, retinal screening (fundoscopy), foot 
assessment and lipids profile, are recommended screening tools to detect long term Diabetes 
complications. The following tables compare the proportions of relevant tests among patient 
groups with or without end organs damage. 
Table 4.5.1 Association between Diabetes complications and relevant screening tests or exams: 
 RFT DONE  RFT NOT Done P-value 
Kidney problems 12 (85.7%) 2 (14.3%) 0.005 
No kidney problems 117 (47.4%) 130 (52.6%)  
 Fundoscopy DONE Fundoscopy NOT Done  
Eye Problems 38 (55.9%) 30 (44.1%) 0.000 
No eye problems 39 (20.2%) 154 (79.8%)  
 Foot exam DONE Foot exam NOT Done  
Foot problems 22 (37.9%) 36 (62.1%) 0.009 
No foot problems 43 (21.1%) 160 (78.8%)  
 Lipids profile DONE Lipids profile NOT Done  
Heart problems 8 (9.7%) 74 (90.2%) 0.55 
NO heart problems 22 (11.1%) 175 (88.8%)  
 
 
Table 4.5.2 Binary univariate logistic regression predicting the effects of developing Diabetes 
complications on performing complications performing measures: 
Complication vs. Test or exam OR (95% CI) P-value 
Eye problems vs. Fundoscopy 5.2 (2.7-9.0) 0.000 
Foot problems vs. Foot exam 2.2 (1.2-4.2)  0.010    
Kidney problems vs. RFT 6.7 (1.4-30.4) 0.014 
Heart problems vs. Lipids profile 1.3 (0.5-3.0) 0.551 
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5. DISCUSSION 
5.1 Overview 
The results of our study is discussed in the context of the national guidelines on management of 
type 2 diabetes in Sudan, in addition to similar regional and international studies in case 
management and barriers to diabetes care. 
In the current study, females were found to have a higher ration than males. This trend is 
compatible with several international and regional reports indicating higher prevalence of type 2 
diabetes among females (37-40). As our study was hospital based, it is expected that females will 
have greater attendance and better care seeking behavior. For example, Feaz B. et al(41) studied 
the role of gender in attending type 2 diabetes clinics and they showed that 74.2% of attendants 
were females.  
In general, the results indicated that the diabetes care in outpatient clinic was inadequate. The 
adherence to the management guidelines differs between areas of diabetes care. High adherence 
area was clinical history. Care providers showed greater compliance with documenting the 
clinical history of diabetes, related complications and medications as the percentages were 75%, 
72% and 87% respectively. Smoking history was an exception as it was documented in only 13% 
of reviewed medical records. As noted from the patients’ questionnaire, it was disturbing that 47 
patients (18%) were current smokers given the close relation between smoking and diabetes 
related complications. Another interesting observation was that all the patients who were asked 
about smoking status were males. It may be due to cultural reasons that asking females about 
smoking status is not appropriate. 
An important factor in assessing the management of type 2 diabetes is measuring the number of 
patients achieving the standard targets of glycemic control, metabolic control and complications 
screening. The available data in the public hospitals on the results of different diabetes 
investigations was lacking. Thus, achievement of diabetes therapeutic targets was studied in the 
specialized diabetes center only. Nevertheless, certain results of our study such as 
hospitalization, complications and associated comorbidities can reflect on the management 
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outcome. The results from patients’ questionnaire showed that more than 25% of patients had at 
least one diabetes related complication. One third of patients were diagnosed with hypertension 
which can be a diabetes related complication or a coexisting disease. Furthermore, 36.4% of 
patients reported previous hospitalization due to diabetes related causes, although rate of 
hospitalization is usually higher among diabetes patients than in the general population.   
Another important factor in the follow up of diabetes patients is medical documentation. As 
suggested by the results, patients reported excess of received diabetes measures in comparison to 
what is documented. The previous finding indicates a deficiency in documentation of the 
measures performed during the medical consultations. Documentation of diabetes visits was 
more competent in the specialized center, which could be due to the using of predesigned 
medical files and training of staff on management of diabetes.  
Somewhat surprisingly, 66.3% of patients reported monthly visits for follow up of diabetes given 
that outpatient visits are recommended every three months. The previous finding was higher than 
other published studies including ones conducted in developed countries (42-45). We cannot 
explain why patients attended diabetes clinics more frequently other than speculate on certain 
factors. First, almost 60% of our patients were enrolled in health insurance coverage. In order to 
purchase medications funded by the health insurance, the request must be performed by a 
physician during the outpatient clinic. Second, only 21% of patients had home glucometer, thus 
monitoring of glycemic control was based on laboratory testing. Third, underutilization of 
HbA1c in glycemic monitoring, which was documented in 22.9% of patients may represent 
another factor. In contrast to HbA1c, which is required 2-3 times a year, blood glucose tests 
(FBG and RBG) are required more frequently. Lastly, the limited time during outpatient clinics 
and the delay in obtaining laboratory results force patients to repeat follow up visits.  
 
5.2 Glycemic control 
Among our patients, 67% had blood glucose level tests (FBG or RBG) documented in their 
medical records. The blood glucose tests are beneficial in measuring the current blood glucose 
level but not suitable in monitoring long term glycemic control. Several guidelines agreed on 
HbA1c as the gold standard test for monitoring glycemic control (25-27), although there is 
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variation on the recommended target level. The test is currently recommended for diagnosing 
new cases of diabetes (44). Moreover, several studies indicate that glycosylated hemoglobin is a 
prognostic factor in developing certain diabetes complications (49-51). Reduction of HbA1c by 
1% reduces the risk of microvascular complications (retinopathy, nephropathy and neuropathy) 
by 40% (52) and reduces mortality by 21% (53). 
It was surprising that only 22.9% of medical records documented HbA1c level within the past 4 
months. The percentage was higher when patients were interviewed (35% of patients had HbA1c 
reports). Although there is discrepancy between performance and documentation, both remain 
below the expected level. In comparison to the specialized diabetes center, the percentage 
showed no statistical difference as 35% of records contained values for HbA1c. These 
percentages are comparable to similar studies performed in Lebanon, Cyprus and Nigeria (40, 
46, 47), in contrast to the higher performance rate shown in several studies in developed 
countries (41-44).  
The previous results can reflect shortage on performance or documentation of HbA1c by care 
providers. Also, it is usually cited that one of the barriers to the use of HBA1c is the high cost of 
the test, which can reach, in Sudan, 10 times the cost of RBG. Currently, The WHO has called to 
increase the availability of the test in lower and middle income countries (LMICs) by reducing 
the cost. Therefore, the test is not yet an established practice in LMICs as compared to high 
income countries.  
 
5.3 Lipids control 
Dyslipidemia is a major cause of cardiovascular disease in type 2 diabetes patients. It is 
recommended that screening for lipids abnormalities should be conducted annually. Lipids 
lowering drugs are recommended in patients with levels of cholesterol and LDL higher than 200 
and 100 mg, respectively.  In our study, 17% of medical records included results of lipids profile 
test while 31% of patients had reports of lipids profile. Although, the documentation 
underestimated the performed number of tests, both percentages shows low adherence to the 
recommendations.  The figures from the specialized diabetes center were significantly higher as 
38.9% of patients’ files contained values of lipids profile test. 
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Another observation was that all medial files documented measures of total cholesterol and LDL 
while other items of the lipids profile such as HDL and triglycerides were not included. The 
previous observation may be due to shortage in the performance of care providers or the nature 
of the available lipids profile test in Sudan. It is frequently cited that hypertriglyceridemia is the 
most commonly detected lipids abnormality in type 2 diabetes patients (30-32). Moreover, a 
study conducted in Sudan to describe the patterns of lipids changes in 250 type 2 diabetes 
patients compared to a control group of healthy people (33). Levels of HDL and triglycerides 
were the only items that showed significant difference between the two groups. In the previous 
study, almost half of patients showed an abnormality in lipids profile.     
 
5.4 Barriers to care 
There are several barriers to achieve comprehensive diabetes care, which can be related to 
patients, care providers or the health system. The cross sectional design of our study is not 
suitable for detecting causation of the shortage in the management practice. In the analysis, we 
tried to assess the association between receiving diabetes care measures and certain factors, 
namely health insurance, previous hospitalization and duration of diabetes. Health insurance 
coverage is commonly indicated as a factor in access to diabetes care (34-36).  Although the 
odds of receiving diabetes care measures and investigations were higher among patients with 
health insurance, the difference was not statistically significant. History of previous 
hospitalization usually increases the chances of receiving comprehensive care because of the 
increase in patients’ contact with the health system. Unlike the limited time given to patients in 
an outpatient clinic, during hospital stay physicians use more extensive care plans. In our sample, 
the odds of receiving certain measures such as renal function test and dilated eye exam 
(fundoscopy) were significantly higher in patients with previous history of hospitalization. 
Receiving of fundoscopy was also significantly associated with the duration of diabetes. Patients 
with longer duration since diagnosis with diabetes had higher chances of receiving fundoscopy. 
 Annual screening for diabetes patients is recommended to prevent the diabetes related 
complications by detecting the high risk patients and introducing the relevant clinical 
interventions. Renal function test, foot exam and fundoscopy are directly related to the screening 
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of diabetes associated kidney, foot and eye complications, respectively. An important finding of 
the study was that the previous tests are more frequently used in patients with established 
complications. To elaborate more, 85% of patients with kidney problems received renal function 
test in the past year compared to 47% of patients without kidney problems. Moreover, 
fundoscopy was performed in 56% of patients with eye problems compared to 20% of patients 
without eye problems. Lastly, 38% of patients with diabetes related foot problems received foot 
exam compared to 21% of the patients without the foot problems. The previous finding was 
highly statistically significant (p<0.001). Although our study design and methods are not 
confirmatory, the previous findings could indicate that some physicians tend to use these tests for 
diagnosis and follow up purposes rather the recommended annual screening.  
5.5 Comparison of process of care measures 
Audit of the management practice of diabetes is frequently based solely on clinical records. 
Several studies assess the management according to the frequency of documentation of diabetes 
care measures. Table 5.5 compares the percentages of documentation between our study and 
other relatively similar studies. Some of these studies often have different objectives. 
Consequently, some of the diabetes care measures are missing in the table 5.5. 
Table 5.5: Comparison of documentation of diabetes care process measures: 
Country/YOP 
Sample 
size 
Percentage of recorded received diabetes care measure 
BMI BP 
Foot 
exam 
HbA1c fundoscopy 
Lipids 
profile 
Current 
study 2015 
262 17.9 70.6 14.1 22.9 9.2 17.2 
Saudi 
Arabia
54 
2005
 
138 39 100 27 73 51 69 
Lebanon
47
 
1999 
204  85.8 31.4 39.7 50 93.1 
Turkey
45 
2012 
1790 57.5 84.8 64.6  42.6 89.7 
Bosnia
42
  
2008 
536 25.0 67.2 53.4 26.5 53.7 72.9 
England
55 
2001 
19174  83.6 70.4 83.0 64.6 71.4 
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5.6 Validity and Limitations of the study 
The cross sectional design of the study restricts the possibility of examining the causation of low 
adherence to the management guidelines. Moreover, review of medical records might not be 
highly indicative of the performance of care providers. In outpatient settings, care providers has 
the ability to perform appropriate medical documentation compared to emergency settings. 
Nevertheless, we believe that certain areas such as counseling and physical exams will be less 
documented. Selection bias is expected as sampling targeted high capacity hospitals only. The 
reason was to achieve the desired sample size given the limited data collection period and the 
paucity of type 2 diabetes patients in small health facilities. 
In addition, two hospitals authorities refused to participate in the study, which may alter the 
obtained results. Patients were asked to report on diabetes care measures received in the past 
year, representing a possibility of recall bias. Finally, research assistants were recruited in data 
collection because outpatient clinics were often conducted in the same time in different hospitals. 
Although, the research assistants were trained on reviewing of medical records and interviewing 
of patients, minor differences may occur in the collected data. 
The previous limitations may reduce the internal and external validity of the study, but it is 
valuable in describing the management practice for type 2 diabetes in Sudan. 
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6. Conclusions and recommendations 
6.1 Conclusion 
The aim of the study was to describe the management and follow up of type 2 diabetes patients 
in relation to the national guidelines. The study identifies various areas of suboptimal diabetes 
care for potential improvement. Based on revised clinical notes, screening for diabetes 
complications is a low adherence area as the screening tests were documented in less than one 
third of the tested sample.  
The study underscored the discrepancy between the documented diabetes care measures and the 
performed measures as reported by patients, highlighting a deficiency in proper documentation 
of medical consultations.  
It was alarming to note that the comprehensive case management is inadequate in most areas of 
diabetes care. Thus, it emphasizes the importance of multidisciplinary approach to implement the 
guidelines of diabetes management as well as screening and prevention of its complications. It’s 
possible to assume that the study confirms the presence of a gap between the practical guidelines 
and the actual practice in relation to the national guidelines in Sudan. 
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6.2 Recommendations 
The study confirms the gap between the practical guidelines and the actual practice relation to 
the national guidelines in Sudan. As various shortcomings in diabetes care were identified, we 
would like to suggest the following recommendations: 
1) To develop training programs for diabetes management that focus on the preventive 
aspect and screening of complications rather than glycemic control and symptomatic 
treatment only.   
 
2) Diabetes is a complex disorder.  There is an urgent need for a systematic approach to care 
which should be facilitated by the use of Disease register Recall system, Flow charts and 
Review charts. 
 
 
3) To initiate a nationwide standard chronic care model that follows strictly guidelines as it 
has the potential to improve care and reduce costs. 
 
4) To develop a standardize assessment tool for routine auditing of diabetes care and follow 
up. 
 
5) To conduct studies with larger sample size and prospective design to assess the barriers to 
diabetes care and quantify the outcome of diabetes management. 
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Annexes 
Annex 1 Medical records review tool 
                                               University of Oslo 
                                    International Community Health 
                         Diabetes Management Guidelines in Outpatient clinics 
Records review Checklist 
No. Review topics Response category* 
Section 1: Elements reviewed REGULARLY 
 Long term and/or recent diabetes history  
 Complications history and/or symptoms  
 Drug history / current drugs  
 Smoking status   
 Blood Pressure measurement (serial readings)***  
 Weight / Height ***  
 Serial blood glucose tests ***  
 HbA1c tested within 4 months ***  
Section 2: Elements reviewed ANNUALLY** 
 Foot examination  
 Peripheral Pulses examination  
 Eye vision examination(Retinal screening)   
 Lipid profile (Esp. Cholesterol/ LDL ***)  
 Urine protein / Urine albumin excretion***  
 Serum creatinine***   
 
Hospital type: ....................................       Date of case extraction: ..../..../....... 
Patient age: .......... 
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Annex 2 Patients’ questionnaire 
                                               University of Oslo 
                                    International Community Health 
                         Diabetes Management Guidelines in Outpatient clinics 
Questionnaire for type 2 diabetes patients  
Date__/__/__ 
Q1 Age: _______ 
Q2 Gender:            Female                                    Male  
Q3 Duration since diagnosis of Diabetes: _______ 
Q4 Do you have Glucometer ( Blood sugar measuring device) at home? 
           Yes                                         No 
 Q4.1 How often do you check your blood sugar at home? _________ 
  Q4.2 Do you record your blood sugar test results for your doctor visits? 
         Yes                                           No  
Q5 Do you have a meal plan for Diabetes? 
        Yes                                              No 
Q5.1 How often do you follow this plan? 
        Never                      Seldom                        Sometimes                     Usually                     
Always 
Q6 Do you use tobacco (smoke cigarettes)?  
        Yes   How many_________                                 No                         Quit, how 
long ago? _______ 
Q7 In the last 12 months, how many times have you had a diabetes routine 
checkup (excluding the current visit)? 
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       None                Once                    Twice                  Three or more                         
Don't know   
Q8 Check any of the following tests/ procedures the patient had in the last 12 
months: 
     Dilated eye exam (Fundoscopy) 
     Foot exam - self 
     Foot exam - Healthcare professional 
     Dietary consultation - Dietician 
     Blood pressure measurement - Healthcare professional                       
__________   
     Weight measurement - Healthcare professional                                    
__________ 
     HbA1c ( a test to measure the average control in the last 3 months) __________  
(last available result)  
   Serum creatinine/ RFT                                                                                   
__________  (last available result) 
   Cholestrol level/ Lipid profile                                                                        
__________ (last available result) 
Q9 Do you have any of the following? 
   Eye problems  
   Kidney problems  
   Numbness/tingling/ loss of sensation in your feet  
   High blood pressure 
   Heart problem  
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Please list any other medical conditions 
_____________________________________ 
__________________________________________________________________
____ 
Q10 In the last 12 months, how many times you have been admitted to the hospital 
(overnight stay)? 
___________ 
Q10.1 What was the reason for your most recent hospital stay related to? 
     DM                                something else                                don't know 
Q 11 Do you take Diabetes medications? 
      Yes                                    No 
Q11.1 Choose the medications that apply to the patient: 
      Oral antidiabetic only 
      Insulin injections only 
      Combinations of oral antidiabetics and insulin injections 
Q11.2 Do you take any other medications? 
      Yes                                    No 
Q12 Do you have a valid health insurance? 
     Yes                                    No 
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